Fennec Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

Fennec Pharmaceuticals

07/11/2024 14:43

* Fennec Pharmaceuticals Inc  FENC.OQ  reported a quarterly
adjusted loss of 21 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of -7 cents.  The mean expectation of
four analysts for the quarter was for a loss of 9 cents per
share. Wall Street expected results to range from -14 cents
to -2 cents per share.
    * Revenue rose 12.8% to $6.97 million from a year ago;
analysts
expected $8.98 million. 
    * Fennec Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 21 cents​.
    * The company reported a quarterly loss of $5.74 million.
    * Fennec Pharmaceuticals Inc shares had fallen by 1.0% this
quarter and lost 55.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1,030.7% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Fennec
Pharmaceuticals Inc is 14.50 
This summary was machine generated from LSEG data November 7 at
02:43 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.09          -0.21          Missed
 Jan. 1 0001       -0.03          -0.20          Missed
 Mar. 31 2024      0.26           0.47           Beat
 Dec. 31 2023      -0.02          -0.10          Missed